MENU
+Compare
NVCR
Stock ticker: NASDAQ
AS OF
Aug 11, 04:59 PM (EDT)
Price
$10.92
Change
-$0.21 (-1.89%)
Capitalization
1.24B

NVCR NovoCure Limited Forecast, Technical & Fundamental Analysis

NovoCure Ltd is an oncology company with a propreitary platform technology in United States... Show more

NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NVCR with price predictions
Aug 08, 2025

NVCR in +2.55% Uptrend, growing for three consecutive days on July 23, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where NVCR advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

NVCR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NVCR as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NVCR turned negative on July 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

NVCR moved below its 50-day moving average on July 11, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NVCR crossed bearishly below the 50-day moving average on July 15, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NVCR entered a downward trend on August 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NVCR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.561) is normal, around the industry mean (57.379). P/E Ratio (0.000) is within average values for comparable stocks, (37.765). NVCR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.644). NVCR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (1.935) is also within normal values, averaging (90.474).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NVCR is expected to report earnings to rise 18.61% to -42 cents per share on October 23

NovoCure Limited NVCR Stock Earnings Reports
Q3'25
Est.
$-0.43
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.18
Q4'24
Missed
by $0.25
Q3'24
Beat
by $0.05
The last earnings report on July 24 showed earnings per share of -36 cents, beating the estimate of -37 cents. With 573.27K shares outstanding, the current market capitalization sits at 1.24B.
A.I. Advisor
published General Information

General Information

a commercial-stage oncology company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
Grenville Street
Phone
+44 1534756700
Employees
1453
Web
https://www.novocure.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SUTZX16.340.11
+0.68%
AB Sustainable US Thematic Z
QUERX21.560.11
+0.51%
AQR Large Cap Defensive Style R6
NWHLX11.180.05
+0.45%
Nationwide Bailard Intl Eqs M
FASMX21.990.04
+0.18%
Fidelity Asset Manager 50%
BFTHX62.33-0.95
-1.50%
Baron Fifth Avenue Growth Retail

NVCR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with AZTA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then AZTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
-3.30%
AZTA - NVCR
39%
Loosely correlated
-0.34%
BLFS - NVCR
38%
Loosely correlated
N/A
TWST - NVCR
38%
Loosely correlated
+2.56%
TMCI - NVCR
37%
Loosely correlated
+7.92%
ITGR - NVCR
37%
Loosely correlated
+0.69%
More

Groups containing NVCR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
-3.30%
Medical/Nursing Services
industry (227 stocks)
34%
Loosely correlated
+0.31%
Health Services
industry (442 stocks)
29%
Poorly correlated
+0.88%